0 Kommentare
0 Anteile
44 Ansichten
Search
Entdecken Sie neue Leute, neue Verbindungen zu schaffen und neue Freundschaften
-
NEUIGKEITEN
- EXPLORE
-
Seiten
-
Gruppen
-
Blogs
-
Foren
-
Please log in to like, share and comment!
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. With the effectual use of technology, innovative applications and expertise, Blood Cancer Market...0 Kommentare 0 Anteile 28 Ansichten
-
Breast Cancer Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Kommentare 0 Anteile 31 Ansichten
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Kommentare 0 Anteile 4KB Ansichten
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Kommentare 0 Anteile 1KB Ansichten
-
Hematology Oncology Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Hematology Oncology Market The global hematology oncology market size was valued at USD 10.98 billion in 2025 and is expected to reach USD 20.02 billion by 2033, at a CAGR of 7.80% during the forecast period The wide ranging Hematology Oncology Market report provides an...0 Kommentare 0 Anteile 55 Ansichten
-
Hematology Oncology Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Hematology Oncology Market The global hematology oncology market size was valued at USD 10.98 billion in 2025 and is expected to reach USD 20.02 billion by 2033, at a CAGR of 7.80% during the forecast period The wide ranging Hematology Oncology Market report provides an...0 Kommentare 0 Anteile 64 Ansichten
-
Tecentriq Market Industry Size and Emerging TrendsThe global oncology therapeutics industry is experiencing rapid advancement due to the increasing prevalence of cancer and the growing adoption of immunotherapy-based treatments. Tecentriq, an immunotherapy drug widely used in cancer treatment, has gained strong recognition for its effectiveness in managing various forms of cancer, including lung cancer and urothelial carcinoma. The increasing...0 Kommentare 0 Anteile 345 Ansichten
-
Uterine Carcinosarcoma Market Size, Share and Trends Forecast to 2029According to the latest report published by Data Bridge Market Research, the Uterine Carcinosarcoma Market Data Bridge Market Research analyses a growth rate in the global uterine carcinosarcoma market in the forecast period 2022-2029. The expected CAGR of global uterine carcinosarcoma market is tend to be around 6.50% in the mentioned forecast period. The market was valued at...0 Kommentare 0 Anteile 198 Ansichten